Method for predicting the presence of congenital and therapeutic conditions from coagulation screening assays
AssigneeAkzo Nobel N.V.
InventorsThomas B. Givens, Paul Braun, Timothy J. Fischer
Life of this patent
Estimating the term…
Loading patent…
AssigneeAkzo Nobel N.V.
InventorsThomas B. Givens, Paul Braun, Timothy J. Fischer
Estimating the term…
A method and apparatus are disclosed for predicting the presence of at least one congenital or acquired imbalances or therapeutic condition associated with thrombosis/hemostasis from at least one time-dependent measurement profile. At least one time-dependent measurement in a sample is performed and a respective property of sample is measured over time so as to derive a time-dependent measurement profile. A set of a plurality of predictor variables are defined which sufficiently define the data of the time-dependent measurement profile. A model is then derived that represents the relationship between the congenital or acquired imbalance or therapeutic condition, and the set of predictor variables. Subsequently, the model is utilized to predict the existence of the congenital or acquired imbalance or therapeutic condition in a sample.
A method for predicting the presence of at least one congenital or acquired imbalance or therapeutic condition associated with thrombosis or hemostasis from at least one time-dependent measurement profile, comprising;
A method for predicting the presence of heparin in a sample, from at least one time-dependent measurement profile, comprising:
Dependencies are inferred from the claim text.